TY - JOUR
T1 - Plasma Exchange Therapy in Postural Tachycardia Syndrome
T2 - A Novel Long-Term Approach?
AU - Wells, Rachel
AU - Hissaria, Pravin
AU - Elliott, Adrian D.
AU - Sanders, Prashanthan
AU - Page, Amanda
AU - Baumert, Mathias
AU - Lau, Dennis H.
N1 - Funding Information:
Funding: This work is supported by Equipment Grants from the Adelaide Medical School, The University of Adelaide (UoA) and the Tom Simpson Trust Fund, Heart Foundation of Australia (HFA) South Australia Division. Conflicts of Interest: PH and MB report none. RW is supported by scholarships from the National Health and Medical Research Council of Australia (NHMRC) and the Australian Government Research Training Program. ADE is supported by the HFA. PS is supported by a practitioner fellowship from NHMRC and HFA and reports having served on the advisory board of Biosense-Webster, Medtronic, Abbott, Boston Scientific and CathRx. PS reports lecture and/or consulting fees from Biosense-Webster, Medtronic, Abbott, and Boston Scientific and research funding from Medtronic, Abbott, Boston Scientific, Biotronik and Liva Nova. AP is supported by a University of Adelaide Beacon Research Fellowship. DHL is supported by a Robert J. Craig Lectureship from the University of Adelaide and The Hospital Research Foundation. DHL reports receiving lecture and/or consulting fees from Abott Medical, Bayer, Biotronik, Boehringer Ingelheim, BMS/Pfizer and Medtronic.
PY - 2020/4
Y1 - 2020/4
N2 - Established therapies for postural tachycardia syndrome (POTS) are limited with moderate efficacy.1 Autoantibodies such as those directed against adrenergic, cholinergic, and acetylcholine receptors have been identified from the plasma of patients with POTS.2,3 We present the first published report of the benefits of long-term maintenance plasma exchange in a young woman with POTS.
AB - Established therapies for postural tachycardia syndrome (POTS) are limited with moderate efficacy.1 Autoantibodies such as those directed against adrenergic, cholinergic, and acetylcholine receptors have been identified from the plasma of patients with POTS.2,3 We present the first published report of the benefits of long-term maintenance plasma exchange in a young woman with POTS.
UR - https://www.scopus.com/pages/publications/85076836027
U2 - 10.1016/j.amjmed.2019.10.016
DO - 10.1016/j.amjmed.2019.10.016
M3 - Article
C2 - 31715171
AN - SCOPUS:85076836027
SN - 0002-9343
VL - 133
SP - e157-e159
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 4
ER -